SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantirs rally to fresh highs is drawing attention after bullish analyst upgrades, including Goldman Sachs Buy rating, which cited opportunities in sovereign AI and customized software. Bulls are celebrating the breakout and pushing back on bearish bets, while skeptics argue the valuation is stretched and warn of a pullback.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas Nasdaq-100 reentry, bringing index-fund buying, and a planned NIH cancer-vaccine initiative are driving attention, alongside optimism about its Merck-partnered melanoma vaccine and upcoming clinical data. Bulls see momentum in the oncology opportunity, while bears argue the rally is outpacing fundamentals and may fade as index-related buying ends.

Polkadot is a platform that allows diverse blockchains to transfer messages, including value, in a trust-free fashion; sharing their unique features while pooling their security. In brief, Polkadot is a scalable heterogeneous multi-chain technology.  Polkadot is heterogeneous because it is entirely flexible and makes no assumption about the nature or structure of the chains in the network. Even non-blockchain systems or data structures can become parachains if they fulfill a set of criteria.  Polkadot may be considered equivalent to a set of independent chains (e.g. a set containing Ethereum, Ethereum Classic, Namecoin and Bitcoin) except with important additions: pooled security and trust-free interchain transactability.  Many of the native parachains of Polkadot will be written using a Polkadot Runtime Environment SDK (e.g. Parity Technologies' Substrate).

Polkadot

DOTs sharp rebound from recent lows is driving attention, with traders pointing to technical buying and the proposed dotUSD stablecoin and tokenomics changes as possible supporting narratives. Bullish traders see a recovery taking shape, while skeptics argue the move may be a short-lived bounce amid Polkadots prolonged decline.

Fundrise Innovation Fund LLC operates as a non-diversified, closed-end management investment company. It invests in growing tech companies to help them expand and generate profits. The company was founded on June 7, 2021 and is headquartered in Washington, DC.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

Anticipation of a potential Anthropic IPO is driving interest in VCX as a private-AI investment proxy, with traders also pointing to other private holdings such as OpenAI and Anduril. The debate centers on lockup-related share supply and whether VCXs market price is justified by its estimated NAV: bears see further pressure, while bulls expect IPO-related interest to support the fund.

T-Mobile US, Inc. engages in the provision of wireless communications services under the T-Mobile and MetroPCS brands. It offers postpaid and prepaid wireless voice, messaging and data services, and wholesale wireless services. The company was founded in 1994 and is headquartered in Bellevue, WA.

T-Mobile US Inc

SpaceXs planned acquisition of low-band spectrum to expand Starlink Mobile has raised fears of a future competitor to T-Mobile and contributed to a sharp selloff in wireless shares. Traders are divided between seeing a long-term competitive threat and viewing the reaction as an overreaction, arguing that building a capable terrestrial network will take substantial time and investment.

Take-Two Interactive Software, Inc. engages in the development, publishing, and marketing of interactive software games. Its products are designed for console systems, handheld gaming systems, and personal computers, including smart phones and tablets, and are delivered through physical retail, digital download, online platforms, and cloud streaming services. The company was founded by Ryan A. Brant in 1993 and is headquartered in New York, NY.

Take-Two Interactive Software, Inc.

Anticipation for Grand Theft Auto VIs scheduled launch is the dominant focus, with bullish traders expecting blockbuster sales and a build-up in demand. Skeptics argue the hype is already reflected in the stock and point to uncertainty around the online mode and its monetization, while recent leaks and game reveals have fueled debate over why the enthusiasm has not translated into stronger share performance.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Menlo Park, CA.

Snowflake Inc

Snowflakes strong quarterly results and raised outlook, attributed to accelerating platform consumption and AI adoption, are driving attention. Bulls view the results as evidence that enterprise AI is boosting demand, while skeptics point to the companys high valuation and lack of GAAP profitability and expect gains to face profit-taking.

Valero Energy Corp. engages in the manufacture and marketing of transportation fuels and other petrochemical products. It operates through the following business segments: Refining, Ethanol and Renewable Diesel. The Refining segment consists of refining operations, associated marketing activities, and logistics assets that support its refining operations. The Ethanol segment includes its ethanol operations, associated marketing activities, and logistics assets that support its ethanol operations. The Renewable Diesel covers the operations of Diamond Green Diesel Holdings LLC. The company was founded in 1980 and is headquartered in San Antonio, TX.

Valero Energy Corp.

VLO is drawing attention as tight diesel supplies and unusually strong refining crack spreads support expectations for elevated refinery margins amid geopolitical disruptions. Traders remain divided between the strong refining-fundamentals and breakout case and concerns about profit-taking, stretched valuations, and possible diesel-export restrictions that could pressure margins.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

Reports that OpenAIs revenue run rate fell short of earlier expectations have fueled concerns about AI demand and the durability of chipmakers growth, weighing on semiconductor stocks and prompting discussion of a rotation into software. Traders are split between viewing the pullback as a warning about AI spending and seeing it as a pause in a still-strong chip-demand trend.

Zscaler, Inc. engages in the provision of a cloud-based internet security platform. It offers Zero Trust Exchange, Zscaler Client Connector, Zscaler Internet Access, Zscaler Private Access, Zscaler B2B, Zscaler Cloud Protection, and Zscaler Digital Experience. The company was founded by Jagtar Singh Chaudhry and K. Kailash in September 2007 and is headquartered in San Jose, CA.

Zscaler Inc

Zscalers Investor Day is driving attention, with management reaffirming its outlook, laying out an ambitious long-term ARR goal, and highlighting an AI-security collaboration with IBM and Red Hat; analysts responded with several target increases. Traders largely welcomed the update and cybersecurity momentum, though some warn the stock is extended or overbought and question whether the growth ambition is achievable.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

This OGE Energy Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday

Analysts upgraded Alumis, Sirius XM, OGE Energy, revising their price targets and outlooks.read more...

ALMS Stock Clocks Worst Day After 57% Drop — What Drove The Selloff?

Equity

The selloff followed topline results from the Phase 2b LUMUS trial of envudeucitinib in moderate-to-severe systemic lupus erythematosus, or SLE, a chronic autoimmune disease in which the body's immune system mistakenly attacks healthy tissues. 


Why Is Alumis Stock Falling Tuesday?

Alumis (ALMS) stock drops over 50% after Phase 2b lupus trial misses overall endpoints, but sub-group data shows promise.read more...

Alumis Psoriasis Treatment Shows Leading Skin Clearance Rates

Alumis releases long-term data for psoriasis drug envudeucitinib, boasting top skin clearance rates ahead of a Q4 FDA filing with FDA.read more...

4 Psoriasis Drug Stocks to Watch During Psoriasis Awareness Month 2026

PTGX, ALMS, ORKA and VNDA offer diverse psoriasis opportunities, spanning approved therapies, late-stage candidates and earlier-stage programs.

Prothena (PRTA) Reports Q2 Loss, Misses Revenue Estimates

Prothena (PRTA) delivered earnings and revenue surprises of +17.95% and -1.94%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

This Biotech Stock Is Up 355%. One Fund Added a $169 Million Position Last Quarter

Key PointsDeep Track Capital bought 6,772,595 shares of Alumis last quarter; the estimated transaction value was $169.31 million (based on average prices...

Alumis Stock Has Soared 400%. Cormorant Bought Another $8 Million Last Quarter

Key PointsCormorant bought 313,645 additional Alumis shares in the first quarter; the estimated trade size was $7.84 million (using average prices in the quarter...

Alumis Stock Is Up Over 300%. One Major Healthcare Investor Is Cutting Back

Key PointsOmega Fund Management sold 411,968 shares of Alumis; the estimated trade value is $10.3 million (based on quarterly average price...

This Alumis Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday

Top analysts changed outlook on top names. See all rating changes on analyst ratings page. Check out analysts' views on ALMS stock.read more...

Alumis, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. It focuses on building a pipeline of molecules with the potential to address a broad range of immune-mediated diseases such as monotherapy or combination therapies. The company was founded on January 29, 2021 and is headquartered in San Francisco, CA.

Alumis Inc.

Extremely Bearish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$7.16
Prev Close	$6.97
Open	$7.04
Dividend Yield	0.00%
50-Day Moving Average	$16.09
Beta	1.14
Avg. Volume	5.05M
PE Ratio	-1.83

52-Week High	$31.35
52-Week Low	$4.28
Market Capitalization	$930.46M
EPS (Annual)	-$2.86
Price to Book	1.98
Revenue Per Employee	$107,366.07

Feed

News

Sentiment

Earnings

Fundamentals

Info

ALMS Fundamentals